Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Iran J Kidney Dis ; 9(2): 97-104, 2015 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-25851287

RESUMO

INTRODUCTION: Vitamin E is a fat-soluble vitamin that functions as an antioxidant. The aim of this study was to investigate the effects of vitamins E supplementation in combination with antibiotics for the treatment of girls with acute pyelonephritis. MATERIALS AND METHODS: This double-blinded randomized controlled trial was conducted on 152 girls aged 5 to 12 years with a first acute pyelonephritis episode based on technetium Tc 99m dimercaptosuccinic acid (99mTc-DMSA). They were randomized to receive a 14-day treatment with only antibiotics (control group; n = 76) and 14-day treatment with supplements of vitamin E (intervention group; n = 76) in addition to the antibiotics. Patients' clinical symptoms were monitored for 14 days and urine culture was performed 3 to 4 days and 7 to 10 days after the start of the treatment and its completion, respectively. All of the girls once underwent DMSA scan 4 to 6 months after the treatment. RESULTS: During the follow-up days, the mean frequency of fever (P = .01), urinary frequency (P = .001), urgency (P = .003), dribbling (P = .001), and urinary incontinence (P = .006) were significantly lower in the intervention group compared to the control group. There was no significant difference in the results of urine culture 3 to 4 days after the start of treatment (P = .16) and 7 to 10 days after its termination (P = .37). There was also no significant difference between the results of DMSA scan 4 to 6 months after the start of treatment (P = .31). CONCLUSIONS: Vitamin E supplementation has a significant effect in ameliorating sign and symptoms of UTI. However, further studies are recommended to confirm these findings.


Assuntos
Antibacterianos/uso terapêutico , Pielonefrite/dietoterapia , Pielonefrite/tratamento farmacológico , Infecções Urinárias/tratamento farmacológico , Vitamina E/uso terapêutico , Doença Aguda , Adjuvantes Farmacêuticos/administração & dosagem , Adjuvantes Farmacêuticos/uso terapêutico , Antibacterianos/administração & dosagem , Antioxidantes/uso terapêutico , Criança , Pré-Escolar , Suplementos Nutricionais , Método Duplo-Cego , Feminino , Seguimentos , Humanos , Pielonefrite/diagnóstico por imagem , Pielonefrite/etiologia , Pielonefrite/fisiopatologia , Cintilografia , Ácido Dimercaptossuccínico Tecnécio Tc 99m/metabolismo , Resultado do Tratamento , Infecções Urinárias/complicações , Vitamina E/administração & dosagem
2.
Appl Radiat Isot ; 65(5): 528-33, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17350271

RESUMO

We studied the influence of a commercial extract of Paullinia cupana (guarana) on the binding of technetium-99m-dimercaptosuccinic acid ((99m)Tc-DMSA) on blood constituents. Plasma (P) and blood cells (BC) from Wistar rats (control and treated) were separated. P and BC were precipitated with trichloroacetic acid (TCA) or ammonium sulphate (AS) and soluble (SF) and insoluble fractions (IF) isolated. The percentage of incorporated radioactivity (%ATI) in each fraction was determined. The treatment influenced the %ATI in IF-P and in IF-BC isolated by TCA precipitation.


Assuntos
Células Sanguíneas/metabolismo , Paullinia/química , Extratos Vegetais/farmacologia , Plasma/metabolismo , Ácido Dimercaptossuccínico Tecnécio Tc 99m/metabolismo , Animais , Células Sanguíneas/efeitos dos fármacos , Feminino , Técnicas In Vitro , Plasma/efeitos dos fármacos , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA